¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"Wiskott-Aldrich Syndrome Protein, Neuronal"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 20
  • ¿µ¹®
    ÇѱÛ
  • supine hypotensive syndrome
    ´©¿îÀÚ¼¼ÀúÇ÷¾ÐÁõÈıº, ¾Ó¿ÍÀ§ÀúÇ÷¾ÐÁõÈıº
  • syndrome
    ÁõÈıº
  • syndrome of crocodile tears
    ¾Ç¾î´«¹°ÁõÈıº
  • syndrome of inappropriate antidiuretic hormone
    Ç×ÀÌ´¢È£¸£¸óºÎÀûÀýºÐºñÁõÈıº
  • syndrome of inappropriate antidiuretic hormone secretion
    Ç×ÀÌ´¢È£¸£¸óºÎÀûÀýºÐºñÁõÈıº
  • syndrome of inappropriate secretion of antidiuretic hormone
    Ç×ÀÌ´¢È£¸£¸óºÎÀûÀýºÐºñÁõÈıº
  • syndrome X
    ÁõÈıºX
  • systemic inflammatory response syndrome
    Àü½Å¿°Áõ¹ÝÀÀÁõÈıº
  • Sertoli-cell-only syndrome
    ¼¼¸£Å縮¼¼Æ÷´Üµ¶ÁõÈıº
  • severe acute respiratory syndrome
    ÁßÁõ±Þ¼ºÈ£ÈíÁõÈıº
  • shaken baby syndrome
    Èçµé¸°¾ÆÀÌÁõÈıº
  • Sheehan¡¯s syndrome
    ½ÃÇÑÁõÈıº
  • short-bowel syndrome
    ªÀºÃ¢ÀÚÁõÈıº
  • shoulder-hand syndrome
    ¾î±ú¼ÕÁõÈıº
  • Shy-Drager syndrome
    »þÀÌ-µå·¡°ÅÁõÈıº
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 20
  • ¿µ¹®
    ÇѱÛ
  • Stein Leventhal syndrome
    ½ºÅ¸ÀÎ-·¹º¥Å»ÁõÈıº.
  • Stevens-Johnson syndrome
    ½ºÆ¼ºì½º-Á¸½¼ÁõÈıº
  • Stewart-Treves syndrome
    ½ºÆ©¾îÆ® Æ®¸®ºê½º ÁõÈıº
  • Stickler syndrome
    ½ºÆ¼Å¬·¯ ÁõÈıº.
  • Stipples syndrome
    ½ºÆ¼Çà ÁõÈıº.
  • Sturge Weber syndrome
    ½ºÅÍÁö-¿þ¹öÁõÈıº.
  • Tietzes syndrome
    ƼÂÅÁõÈıº.
  • Turners syndrome
    ÅÍ³Ê ÁõÈıº
  • Ushers syndrome
    ¾Æ¼ÅÁõÈıº
  • V-syndrome
    VÁõÈıº
  • V-syndrome
    V ÁõÈıº
  • Vogt-Koyanagi syndrome
    Æ÷±×Æ® °í¾ß³ª±â ÁõÈıº
  • Vogt-Koyanagi-Harada syndrome
    º¸Å©Æ®-°í¾ß³ª±â-Ç϶ó´Ù ÁõÈıº
  • WPW syndrome
    WPWÁõÈıº, ºÎÀüµµ·ÎÁõÈıº .
  • Waardenburgs syndrome
    ¹Ù¸£µ§ºÎ¸£Å© ÁõÈıº
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 20
  • ¿µ¹®
    ÇѱÛ
  • bronze baby syndrome
    ûµ¿»ö¾Æ±âÁõÈıº
  • bruising syndrome
    Ÿ¹Ú»óÁõÈıº.
  • budd-chiari syndrome
    ¹Ùµå-Ű¾Æ¸® ÁõÈıº (¡­ñøý¦ÏØ)
  • bulbar syndrome
    ¿¬¼öÁõÈıº(æÅâÐñøý¦ÏØ)
  • burning feet syndrome
    ÀÛ¿­°¢ÁõÈıº(¡­ñøý¦ÏØ), ¼ÒÀÛÁ·ÁõÈıº(áÀíÇðëñøý¦ÏØ).
  • camptomelic syndrome
    ±¼Áö ÁõÈıº.[¼Ò¾Æ]Áöü ±¼°î ÁõÈıº(ò¶ô÷ÏÝÍØñøý¦ÏØ) .
  • camptomelic syndrome
    ±¼ÁöÁõÈıº.¼Ò¾ÆÁöü±¼°îÁõÈıº(ò¶ô÷ÏÝÍØñøý¦ÏØ) .
  • capillary leak syndrome
    ¸ð¼¼Ç÷°ü´©ÃâÁõÈıº
  • caplans syndrome
    ijÀÌÇöõ ÁõÈıº (¡­ñøý¦ÏØ)
  • carbohydrate malabsorption syndrome
    ´çÁúÈí¼öºÒ·®ÁõÈıº(ÓØòõýåâ¥ÝÕÕÞñøý¦ÏØ)
  • carcinoid syndrome
    Ä«¸£½Ã³ëÀ̵åÁõÈıº(¡­ÁõÈıº).
  • carcinoid syndrome
    Ä«¸£½Ã³ëÀ̵åÁõÈıº(¡­ñøý¦ÏØ).
  • carcinoid syndrome
    Ä«¸£½Ã³ëÀ̵åÁõÈıº
  • carcinoid syndrome
    Ä«¸£½Ã³ëÀ̵åÁõÈıº(¡­ñøý¦ÏØ).
  • carcinoid syndrome
    Ä«¸£½Ã³ëÀ̵å ÁõÈıº (¡­ñøý¦ÏØ)
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 20
CHS central hypoventilation syndrome; Chediak-Higashi syndrome; cholinesterase; chondroitin sulfate; com...
CPS carbamoylphosphate synthetase; cardioplegic perfusion solution; centipoise; cervical pain syndrome; ...
CRS Carroll rating scale for depression; catheter-related sepsis; caudal regression syndrome; cervical s...
CSS Cancer Surveillance System; carotid sinus stimulation; carotid sinus syndrome; cavernous sinus syndr...
DGS decompression sickness; developmental Gerstmann syndrome; diabetic glomerulosclerosis; Di George seq...
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 20
DDS Denys Drash syndrome
DGS Di George syndrome
DILS Diffuse Infiltrative Lymphocytosis Syndrome
DIC Disseminated intravascular coagulation syndrome
DS Down Syndrome
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 20
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • malabsorption syndrome
    Èí¼öÀå¾Ö ÁõÈıº
    Á¤°ü¿¡¼­ÀÇ ¿µ¾ç¹° Èí¼öÀÇ Àå¾Ö¸¦ °¡Á®¿À´Â ÁúȯÀ» ÃѰýÇÏ´Â ¸íĪ. ¼³»ç, üÁß °¨¼Ò, ¿µ¾ç½ÇÁ¶¸¦ °¡Á®¿À´Â ¿øÀÎÀÌ µÇ´Â ÁúȯÀº Àå°ü ¼ö¼ú µÚ, Àå Áúȯ, ÃéÀå Áúȯ, °£´ãµµ Áúȯ, ¸²ÇÁÁ¾, ½ÉºÎÀü, ½É³¶¿°, ¾Æ´Ò·ÎÀ̵å½Ã½º, ¥â-Áö¹æ ´Ü¹é °á¼ÕÁõ, ½ºÇª·ç¿ì
  • maladaptation syndrome
    ÀûÀÀ Àå¾Ö ÁõÈıº
  • male Turners syndrome
    ³²¼º ÅÍ³Ê ÁõÈıº
  • malignant hyperthermia syndrome
    ¾Ç¼º °í¿­ ÁõÈıº
  • Mallory-Weiss syndrome
    ¸»·Î¸®-¹ÙÀ̽º ÁõÈıº, ¸È·Î¸®¿ÍÀ̽º ÁõÈıº
    1. ±¸Åä¿¡ ÀÇÇØ ½ÄµµÀ§ °áÇÕºÎÀÇ Á¡¸· ¿­»óÀ» ¸»Çϴµ¥, ¹ß»ý ±âÀüÀ¸·Î´Â ½ÉÇÑ ±¸Åä ½Ã °©ÀÛ½º·± º¹¾ÐÀÇ »ó½ÂÀÌ ¿øÀÎÀÌ µÇ¸ç ȯÀÚ´Â ÁßÁõ ¾ËÄÚ¿Ã Áßµ¶°ú °ü·ÃµÈ ¸¸¼º ±¸ÅäÁõÀÌ ÀÖ´Ù. º´¸® ¼Ò°ßÀ¸·Î´Â À§Àå »óºÎ°¡ º¸Åë ħ¹üµÇ¸ç À§ ºÐ¹®ÀÇ ´ë¸¸ÀÌ °¡Àå ÈçÈ÷ ħ¹üµÈ´Ù. ÅëÁõÀº ¾øÀÌ À§Àå ÃâÇ÷ÀÌ »ý±ä´Ù. ÃâÇ÷ Áõ»óÀº Ç÷º¯º¸´Ù´Â ÅäÇ÷ÀÇ ÇüÅ·Πº¸Åë ³ªÅ¸³­´Ù. Áø´ÜÀº ³»½Ã°æÀ¸·Î Á¡¸· ¿­»óÀ» Áõ¸íÇÏ¿© È®ÁøÇϸç Ä¡·á´Â À§ Àå°ü ÃâÇ÷¿¡ ´ëÇÑ ´ëÁõÀû ¿ä¹ýÀ» ¸ÕÀú ½ÃÀÛÇÏ¿© ¸¸ÀÏ ÃâÇ÷ÀÌ Áö¼ÓµÇ¸é Áï½Ã ¼ö¼úÀ» ½ÃÇàÇÑ´Ù. ¼ö¼ú ÈÄ ¿¹ÈÄ´Â ÁÁ´Ù. 2. ½ÉÇÑ ±¸Åä¿Í ±¸¿ªÀÌ ¸î ½Ã°£ ¶Ç´Â ¸çÄ¥°£ Áö¼ÓµÈ ÈÄ¿¡ ÅäÇ÷, ÇÏÇ÷À» ÀÏÀ¸Å°´Â Áúȯ. 1929³â ¹Ì±¹ º´¸®ÇÐÀÚ G.K. ¸È·¯¸®¿Í ³»°úÀÇ»ç S. ¿ÍÀ̽º
  • Marcus Gunn's syndrome
    ¸¶Äí½º ±º ÁõÈıº
    À̼ø Çö»ó. ÇϾÇÀÇ ¿îµ¿°ú µ¿½Ã¿¡ »ó¾È°ËÀÌ ¿Ã¶ó°¡´Â Çö»ó.
  • medial superior pontine syndrome
    ³» »óÃø ±³»óºÎ ÁõÈıº
  • medulla syndrome
    ¿¬¼ö ÁõÈıº
  • megacystis-megaureter syndrome
    °Å´ë ¹æ±¤-°Å´ë ¿ä°ü ÁõÈıº
    ¹æ±¤ÀÇ È®Àå°ú ÀÌ¿ÏÀ» µ¿¹ÝÇÑ ¸¸¼ºÀû ¿ä°ü È®Àå°ú, ¿ä°ü ÀÔ±¸ÀÇ ºÐ¿­·Î ¿äÀÇ ¹æ±¤ ¿ª·ù¿Í ¸¸¼º ½Å¿ì¿°À» ÀÏÀ¸Å² °Í.
  • meigs syndrome
    ¸ÞÀ̱׽º ÁõÈıº
    ³­¼Ò ¼¶À¯Á¾ ¶Ç´Â °ñ¹Ý³» Á¾¾ç°ú µ¿¹ÝµÇ´Â º¹¼ö¿Í Èä¼ö.
  • Melkersson-Rosenthal syndrome
    ¸áÄ¿½¼ ·ÎÁ¨Å» ÁõÈıº
    À°¾ÆÁ¾¼º ±¸¼ø¿°ÀÌ ´Üµ¶À¸·Î ³ªÅ¸³ª°Å³ª ¼³ ±Õ¿­°ú ¾È¸é ½Å°æ ¸¶ºñ¿Í °ü·ÃµÇ¾î ³ªÅ¸³ª´Â °æ¿ì. ÀÌó·³ ÈçÇÏÁö ¾Ê´Â ¼¼ °¡Áö ¡Èĸ¦ ¸»ÇÑ´Ù.
  • Mendelson's syndrome
    ¸àµ¨½¼ ÁõÈıº
    »ïÃ⼺ ºÎÁ¾, ½ÉÇÑ ±â°üÁö¿°.
  • Meniere's syndrome
    ¸Þ´Ï¿¡¸£ ÁõÈıº
    ¹Ì·ÎÀÇ ºñÈ­³ó¼º º´ÀÎ ³»¸²ÇÁ¼º ¼öÁ¾¿¡¼­ ¿À´Â ³­Ã», À̸í, Çö±â.
  • meningitis syndrome
    ¼ö¸·¿° ÁõÈıº
  • Menkes kinky hair syndrome
    ¸àÄÉ Å²Å° ¸ð ÁõÈıº
    ¹Ý¼º ¿­¼º À¯Àüº´À¸·Î, µ¿ Èí¼öÀÇ ¼±ÃµÀû Àå¾Ö·Î »ý±ä´Ù. ½ÉÇÑ ´ë³ú º¯¼º, µ¿¸Æ º¯È­·Î ¿µ¾Æ±â¿¡ »ç¸ÁÇÑ´Ù.
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 20
proto-oncogene protein p21(ras) Cellular protein encoded by the c-ras genes. The protein has GTPase activity and is involved in transmembrane signal transduction as a guanine nucleotide binding protein. Elevated levels of p21 c-ras have been associated with neoplasia.
(12 Dec 1998)
proto-oncogene protein pp60(c-src) <enzyme> Membrane-associated tyrosine-specific kinase encoded by the c-src genes. It has an important role in cellular growth control. Truncation of carboxy-terminal residues in pp60(c-src) leads to pp60(v-src) which has the ability to transform cells. This kinase pp60 c-src should not be confused with csk, also known as c-src kinase.
Registry number: EC 2.7.1.-
(12 Dec 1998)
heterologous protein A protein that differs from any protein normally found in the organism in question.
Synonym: heterologous protein.
(05 Mar 2000)
prp 27-30 protein Protease-resistant core of prpsc, the abnormal isoform of prion proteins (prions). Prp 27-30 is produced by limited proteolysis of the n-terminus of prpsc.
(12 Dec 1998)
high-mobility group protein <protein> An HMG protein is one of a group of various different proteins which are somehow involved with chromatin, but which are not histones and whose exact function is not known.
(09 Oct 1997)
HIV core protein p24 A major core protein of the human immunodeficiency virus encoded by the HIV gag gene. HIV-seropositive individuals mount a significant immune response to p24 and thus detection of antibodies to p24 is one basis for determining HIV infection by elisa and western blot assays. The protein is also being investigated as a potential HIV immunogen in vaccines.
(12 Dec 1998)
HIV envelope protein gp120 External envelope protein of the human immunodeficiency virus which is encoded by the HIV env gene. It has a molecular weight of 120,000 kD and contains numerous glycosylation sites. Gp120 binds to cells expressing CD4 cell-surface antigens, most notably t4-lymphocytes and monocytes/macrophages. Gp120 has been shown to interfere with the normal function of CD4 and is at least partly responsible for the cytopathic effect of HIV.
(12 Dec 1998)
HIV envelope protein gp160 An envelope protein of the human immunodeficiency virus that is encoded by the HIV env gene. It has a molecular weight of 160,000 kD and contains numerous glycosylation sites. It serves as a precursor for both the HIV envelope protein gp120 and the HIV envelope protein gp41.
(12 Dec 1998)
HIV envelope protein gp41 Transmembrane envelope protein of the human immunodeficiency virus which is encoded by the HIV env gene. It has a molecular weight of 41,000 and is glycosylated. The n-terminal part of gp41 is thought to be involved in cell fusion with the CD4 antigens of t4 lymphocytes, leading to syncytial formation. Gp41 is one of the most common HIV antigens detected by immunoblotting.
(12 Dec 1998)
PTC protein Formed by the reaction of phenylisothiocyanate with a terminal alpha-amino group of a peptide or protein
See: phenylisothiocyanate, phenylthiohydantoin.
Synonym: PhNCS protein, PTC protein.
(05 Mar 2000)
hn protein Glycoprotein from sendai, para-influenza, newcastle disease, and other viruses that participates in binding the virus to cell-surface receptors. The hn protein possesses both haemagglutinin and neuraminidase activity.
(12 Dec 1998)
secretory protein <protein> In eukaryotes, proteins synthesised on rough endoplasmic reticulum and destined for export. Nearly all proteins secreted from cells are glycosylated (in the Golgi apparatus, although there are exceptions (albumin). In prokaryotes, secreted proteins may be synthesised on ribosomes associated with the plasma membrane or exported post translation.
(18 Nov 1997)
purified placental protein human placental lactogen
purified protein derivative of tuberculin Purified tuberculin containing the active protein fraction; the tuberculin from which it is prepared differs from tuberculin chiefly in that the bacteria are grown in a synthetic rather than in a broth medium.
(05 Mar 2000)
housekeeping protein <molecular biology> Those sets of proteins involved in the basic functioning of a cell or the set of cells in an organism, for example enzymes involved in synthesis and processing of DNA, RNA, proteins or the major metabolic pathways. As opposed to luxury proteins.
(18 Nov 1997)
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 20
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 20
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 20
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 20
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 20
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 20
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 20
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 20
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 20
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 20
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 20
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 20
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 20
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 20
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 20
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 20
  • ¿µ¹®
    ÇѱÛ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 20
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 20
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 20
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 20
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 20
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 20
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 20
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 20
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 20
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 20
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 20
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 20
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 20
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 20
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 20
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 20
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 20
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 20
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 20
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 20
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 20
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 20
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 20
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 20
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 20
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 20
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 20
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 20
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 20
  • ¿µ¹®
    ÇѱÛ
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 20
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 20
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 20
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 20
ÅëÇÕ°Ë»ö ¿Ï·á